Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Harmol
Cat. No.:
OB0425LY-402
Appearance:
Solid
Purity:
99.77%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Harmol is a monoamine oxidase inhibitor with anti-tumor, anti-depressant, and anti-aging effects. It plays a key role in induce cell mitosis, autophagy and apoptosis.
Synonyms:
487-03-6; 1-Methyl-9H-pyrido[3,4-b]indol-7-ol; 9H-Pyrido[3,4-b]indol-7-ol, 1-methyl-; 1-Methyl-9H-beta-carbolin-7-ol
CAS No.:
487-03-6
Compound CID:
68094
Formula:
C12H10N2O
Formula Weight:
198.22
Specification
Target:
α-Synuclein
Pathway:
Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
Harmol can be used in animal models and anti-obesity studies.
